SCHEMBL17876302

SCHEMBL17876302

c1ccc(-c2cc(-c3ccc4c(c3)-c3cc(-c5ccc6c(c5)oc5ccccc56)ccc3CN(c3ccccc3)C4)cc(-c3ccccc3)n2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.40
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 4/20 0.40
MAPK1 P28482 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
HPGD P15428 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
PRKDC P78527 2/20 0.35
AHR P35869 2/20 0.35
NPC1 O15118 3/20 0.35
RAB9A P51151 3/20 0.35
ATM Q13315 1/20 0.35
HCRTR1 O43613 2/20 0.35
LMNA P02545 1/20 0.35
GAA P10253 1/20 0.35
EGFR P00533 1/20 0.34
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33
TSHR P16473 3/20 0.32
DHODH Q02127 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876274 0.96 MAPT (0.38) MAPTALDH1A1KDM4EMAPK1L3MBTL1
SCHEMBL17876241 0.96 MAPT (0.38) MAPTALDH1A1KDM4EMAPK1L3MBTL1
SCHEMBL17876309 0.94 MAPT (0.40) MAPTALDH1A1KDM4EMAPK1L3MBTL1
SCHEMBL17876297 0.90 PRKDC (0.41) MAPTALDH1A1KDM4EHPGDPRKDC
SCHEMBL17876293 0.90 NPC1 (0.41) MAPTALDH1A1KDM4EMAPK1HPGD
SCHEMBL17876276 0.90 KDM4E (0.38) MAPTALDH1A1KDM4EMAPK1L3MBTL1
SCHEMBL17876246 0.90 KDM4E (0.38) MAPTALDH1A1KDM4EMAPK1L3MBTL1
SCHEMBL17876308 0.89 ALDH1A1 (0.38) MAPTALDH1A1KDM4EMAPK1L3MBTL1
SCHEMBL17876296 0.88 ALOX5 (0.44) MAPTALDH1A1KDM4EMAPK1L3MBTL1
SCHEMBL17876300 0.86 NPC1 (0.39) MAPTALDH1A1KDM4EMAPK1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 MAPT 2144/4885ALDH1A1 1061/4885KDM4E 3120/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 MAPT 2144/4885ALDH1A1 1061/4885KDM4E 3120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.